C07K 19 - Hybrid peptides - Patents Sitemap

Patents for C07K 19 - Hybrid peptides (29,428)
10/2002
10/29/2002	US6472180 A polynucleotide which encodes a truncated fragment of the hcv ns3 (hepatitis c virus)ns3 protein helicase fragment, such truncated fragment retaining helicase activity and having about 50 amino acids of carboxy terminus deleted
10/29/2002	US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002	US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002	US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002	CA2045552C Cancer related haptoglobin
10/24/2002	WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	WO2002083738A1 Cyclic single strand trispecific antibody
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083181A1 Novel compositions and uses therefor
10/24/2002	WO2001074848A3 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156244 Adipocyte complement related protein zacrp13
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156007 Apolipoprotein analogues
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155972 Detergent compositions comprising benefit agents
10/24/2002	US20020155604 Compositions and methods for regulating lymphocyte activation
10/24/2002	US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155121 Virus coat protein/receptor chimeras and methods of use
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	DE10119804A1 New peptides produced in primates during inflammation and sepsis, useful for diagnosis and treatment of these diseases, and their related antibodies
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444048A1 Novel immunogenic compositions comprising modified and unmodified antigens
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443705A1 Cyclic single strand trispecific antibody
10/24/2002	CA2443408A1 Kinases and phosphatases
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250355A1 Chimeric prostate-homing peptides with pro-apoptotic activity
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP0721470B1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	EP0576623B1 Binding domains in notch and delta proteins
10/23/2002	CN1376165A Materials and methods for inhibition of Lg E production
10/23/2002	CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469143 Antigen/antibody specificity exchanger
10/22/2002	US6468790 Metastatic breast and colon cancer regulated genes
10/22/2002	US6468738 First polypeptide fused to a filamentous phage membrane cpviii anchor domain; mutating immunoglobulin variable domain-coding nucleotide sequence in the provided genome to form library of phage particles; immunoglobulin vh polypeptide (antibody heavy
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468540 Immunotherapeutic stress protein-peptide complexes against cancer
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2095335C Cell growth inhibitors
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081683A2 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	US20020152489 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150984 Peptides for activation and inhibition of deltaPKC
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443067A1 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	CN1374871A FC fusion proteins for enhancing the immunogenicity of protein and piptide antigens
10/15/2002	US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079415A2 Reducing the immunogenicity of fusion proteins
10/10/2002	WO2002079397A2 Virus derived antimicrobial peptides
10/10/2002	WO2002079387A2 Modular molecular clasps and uses thereof
10/10/2002	WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002	WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002	WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002	WO2002004612A3 Drug metabolizing enzymes
10/10/2002	WO2001098353A3 Secreted proteins
10/10/2002	US20020147311 Fusion protein for use in the treatment of tumors
10/10/2002	US20020147306 Peptides that modulate the interaction of B class ephrins and PDZ domains
10/10/2002	US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002	US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002	US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases

1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 295